Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: A double-blind prospective randomized phase III study

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 2, 2002, Pages 479-485

  Saarilahti, Kauko ^a   Kajanti, Mikael ^a   Joensuu, Timo ^a   Kouri, Mauri ^a   Joensuu, Heikki ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

GM CSF; Head and neck cancer; Mucositis; Radiotherapy; Sucralfate

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; OPIATE; SUCRALFATE;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BODY WEIGHT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; MOUTH CAVITY; MUCOSA INFLAMMATION; PAIN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEAD AND NECK NEOPLASMS; HUMAN; LEUKOCYTE COUNT; MALE; MIDDLE AGE; MOUTH MUCOSA; MOUTHWASHES; NEUTROPHILS; PROSPECTIVE STUDIES; RADIATION INJURIES; STOMATITIS; SUCRALFATE; WEIGHT LOSS;

EID: 0036805256     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02935-8     Document Type: Article

References (29)

1. Maciejewski B., Withers H.R., Taylor J.M.G., et al. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses Acute and late effects . Int J Radiat Oncol Biol Phys. 18:1990;101-111.
2. Kaanders J., Ang K.K. Early reactions as dose-limiting factors in radiotherapy. Semin Radiat Oncol. 2:1994;55-67.
3. Denham J.W., Walker Q.J., Lamb D.S., et al. Mucosal regeneration during radiotherapy. Radiother Oncol. 41:1996;109-118.
4. Trotti A. Toxicity in head and neck cancer A review of trends and issues . Int J Radiat Oncol Biol Phys. 47:2000;1-12.
5. Parsons J.T. The effect of radiation on normal tissues of the head and neck. Million R.R., Cassisi N.J., Management of head and neck cancer A multidisciplinary approach . 2nd ed. 1994;245-289 Lippincott, Philadelphia.
6. Maciejewski B., Withers H.R., Taylor J.M.G., et al. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx Tumor dose-response and repopulation . Int J Radiat Oncol Biol Phys. 16:1989;831-843.
7. Fowler J.F., Lindström M.J. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys. 23:1992;457-467.
8. Sutherland S.E., Browman G.P. Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients A proposed classification scheme of interventions and meta-analysis of randomized controlled trials . Int J Radiat Oncol Biol Phys. 49:2001;917-930.
9. Rovirosa A., Ferre J., Biete A. Granulocyte-macrophage colony-stimulating factor mouthwashes heal oral ulcers during head and neck radiotherapy. Int J Radiat Oncol Biol Phys. 41:1998;747-754.
10. Nicolatou O., Sotiropoulou-Lontou A., Skarlatos J., et al. A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during x-ray therapy A preliminary report . Int J Radiat Oncol Biol Phys. 42:1998;551-556.
11. Wagner W., Alfrink M., Haus U., et al. Treatment of irradiation-induced mucositis with growth factors (rhGM-CSF) in patients with head and neck cancer. Anticancer Res. 19:1999;799-803.
12. Lieschke G.J., Burgess A.W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. First Part. N Engl J Med. 327:1992;28-35.
13. Liechke G.J., Burgess A.W. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Second Part. N Engl J Med. 327:1992;99-106.
14. Bennet N.T., Shult G.S. Growth factors and wound healing Biochemical properties of growth factors and their receptors . Am J Surg. 165:1993;728-737.
15. Braunstein S., Kaplan G., Gottielb A.B., et al. GM-CSF activates regenerative epidermal growth and stimulates keratinocyte proliferation in human skin in vivo. J Invest Dermatol. 103:1994;601-604.
16. Da Costa R.M., Aniceto T., Jesus F.M., et al. Quick healing of leg ulcers after molgramostim. Lancet. 344:1994;481-482.
17. Jyung R.W., Wu L., Pierce G.F., et al. Granulocyte macrophage colony-stimulating factor and granulocyte colony-stimulating factor Differential action on incisional wound healing . Surgery. 115:1994;325-334.
18. Masucci G. New clinical applications of granulocyte-macrophage colony-stimulating factor. Med Oncol. 13:1996;149-154.
19. Kannan V., Bapsy P.P., Anantha N., et al. Efficacy and safety of granulocyte-macrophage colony-stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 37:1997;1005-1010.
20. Throuvalas N., Antonadou D., Pullizi M., et al. Evaluation of efficacy and safety of GM-CSF in the prophylaxis of mucositis in patients with head and neck cancer treated with RT. Eur J Cancer. 41A:1997;431.
21. Makkonen T.A., Minn H., Jekunen A., et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis A prospective randomized study . Int J Radiat Oncol Biol Phys. 46:2000;525-534.
22. Epstein J.B., Wong F.L. The efficacy of sucralfate suspension in the prevention of oral mucositis due to radiation therapy. Int J Radiat Oncol Biol Phys. 28:1994;693-698.
23. Makkonen T.A., Boström P., Vilja P., et al. Sucralfate mouth washing in the prevention of radiation-induced mucositis A placebo-controlled double-blind randomized study . Int J Radiat Oncol Biol Phys. 30:1994;177-182.
24. Lievens Y., Haustermans K., Van de Weyngaert D., et al. Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial. Radiother Oncol. 47:1998;149-153.
25. Carter D.L., Hebert M.E., Leopold K.A., et al. Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers. Head Neck. 21:1999;760-766.
26. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
27. Gordon B., Spadinger A., Hodges E., et al. Effect of granulocyte-macrophage colony stimulating factor on oral mucositis after haematopoietic stem-cell transplantation. J Clin Oncol. 12:1994;1917-1922.
28. Chi K.H., Chen C.H., Chan W.K., et al. Effect of granulocyte-macrophage colony stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin. J Clin Oncol. 13:1995;2620-2628.
29. Hejna M., Köstler W.J., Raderer M., et al. Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF Results of a prospective randomized trial . Eur J Cancer. 37:2001;1994-2002.